- Home
- TCMD vs RCKT Comparison
TCMD vs RCKT Comparison
Compare TCMD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- RCKT
- Stock Information
- Founded
- TCMD 1995
- RCKT 1999
- Country
- TCMD United States
- RCKT United States
- Employees
- TCMD N/A
- RCKT N/A
- Industry
- TCMD Medical/Dental Instruments
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- TCMD Health Care
- RCKT Health Care
- Exchange
- TCMD Nasdaq
- RCKT Nasdaq
- Market Cap
- TCMD 314.0M
- RCKT 326.4M
- IPO Year
- TCMD 2016
- RCKT N/A
- Fundamental
- Price
- TCMD $9.97
- RCKT $2.70
- Analyst Decision
- TCMD Hold
- RCKT Buy
- Analyst Count
- TCMD 3
- RCKT 13
- Target Price
- TCMD $16.00
- RCKT $18.50
- AVG Volume (30 Days)
- TCMD 289.6K
- RCKT 8.4M
- Earning Date
- TCMD 08-04-2025
- RCKT 08-04-2025
- Dividend Yield
- TCMD N/A
- RCKT N/A
- EPS Growth
- TCMD N/A
- RCKT N/A
- EPS
- TCMD 0.66
- RCKT N/A
- Revenue
- TCMD $293,164,000.00
- RCKT N/A
- Revenue This Year
- TCMD $7.96
- RCKT N/A
- Revenue Next Year
- TCMD $8.53
- RCKT N/A
- P/E Ratio
- TCMD $15.10
- RCKT N/A
- Revenue Growth
- TCMD 5.96
- RCKT N/A
- 52 Week Low
- TCMD $8.61
- RCKT $2.19
- 52 Week High
- TCMD $21.10
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- TCMD 41.97
- RCKT 32.09
- Support Level
- TCMD $9.80
- RCKT $2.66
- Resistance Level
- TCMD $10.67
- RCKT $3.33
- Average True Range (ATR)
- TCMD 0.34
- RCKT 0.28
- MACD
- TCMD 0.09
- RCKT 0.09
- Stochastic Oscillator
- TCMD 19.54
- RCKT 26.59
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.